Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.27 -0.20 (-2.36%)
At close: Sep 29, 2026 · 4:00 PM EDT

Biocryst Pharmaceuticals (BCRX) Total Current Liabilities (2010 - 2026)

Updated

Biocryst Pharmaceuticals' Total Current Liabilities was $208.85 million in Q2 2026, up 17.9% from $177.16 million a year earlier and up 6.9% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Biocryst Pharmaceuticals came in at $196.07 million, up 22.2% from FY2024.

  • Total Current Liabilities has now increased for four consecutive years, with a five-year compound annual growth rate of 13.2% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $160.38 million in FY2024 (+6.9%), $149.99 million in FY2023 (+42.1%), $105.51 million in FY2022 (+1.7%) and $103.72 million in FY2021 (-1.8%).
  • The Q2 2026 figure marks the highest quarterly Total Current Liabilities in data going back to Q4 2010.
  • Compared with a year earlier, Total Current Liabilities has increased for 12 straight quarters, with growth averaging 29.2% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q3 2024 (growth of 69.2%); the worst was Q3 2022 (a decline of 38.9%).
  • Per Business Quant data, BCRX's Total Current Liabilities in the three quarters before Q2 2026 was $195.39 million (Q1 2026), $196.07 million (Q4 2025) and $190.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Biocryst Pharmaceuticals 2.16 Bn 1.08 Bn 214.41 Mn 208.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 208.85 Mn
Mar 31, 2026 195.39 Mn
Dec 31, 2025 196.07 Mn
Sep 30, 2025 190.24 Mn
Jun 30, 2025 177.16 Mn
Mar 31, 2025 139.86 Mn
Dec 31, 2024 160.38 Mn
Sep 30, 2024 153.57 Mn
Jun 30, 2024 129.07 Mn
Mar 31, 2024 119.92 Mn
Dec 31, 2023 149.99 Mn
Sep 30, 2023 90.76 Mn
Jun 30, 2023 93.50 Mn
Mar 31, 2023 85.16 Mn
Dec 31, 2022 105.51 Mn
Sep 30, 2022 81.64 Mn
Jun 30, 2022 95.39 Mn
Mar 31, 2022 81.02 Mn
Dec 31, 2021 103.72 Mn
Sep 30, 2021 133.61 Mn
API Access

Biocryst Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BCRX&period=max&api_key=YOUR_API_KEY